Inspire Medical Systems, Inc.
INSP
$81.79
-$2.02-2.41%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 882.62M | 861.31M | 840.11M | 802.80M | 755.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 882.62M | 861.31M | 840.11M | 802.80M | 755.59M |
| Cost of Revenue | 133.14M | 133.77M | 128.94M | 122.99M | 115.05M |
| Gross Profit | 749.48M | 727.55M | 711.17M | 679.82M | 640.54M |
| SG&A Expenses | 604.19M | 575.71M | 548.28M | 529.61M | 512.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 845.90M | 819.91M | 790.30M | 766.72M | 742.10M |
| Operating Income | 36.73M | 41.40M | 49.82M | 36.08M | 13.50M |
| Income Before Tax | 52.01M | 58.79M | 71.97M | 58.45M | 37.06M |
| Income Tax Expenses | 7.46M | 5.67M | 5.46M | 4.94M | 4.01M |
| Earnings from Continuing Operations | 44.56 | 53.12 | 66.51 | 53.51 | 33.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.56M | 53.12M | 66.51M | 53.51M | 33.05M |
| EBIT | 36.73M | 41.40M | 49.82M | 36.08M | 13.50M |
| EBITDA | 49.34M | 52.19M | 58.57M | 42.63M | 18.39M |
| EPS Basic | 1.50 | 1.78 | 2.23 | 1.79 | 1.11 |
| Normalized Basic EPS | 1.27 | 1.32 | 1.51 | 1.22 | 0.78 |
| EPS Diluted | 1.46 | 1.72 | 2.16 | 1.72 | 1.07 |
| Normalized Diluted EPS | 1.24 | 1.28 | 1.47 | 1.18 | 0.76 |
| Average Basic Shares Outstanding | 118.37M | 118.92M | 119.14M | 119.05M | 118.74M |
| Average Diluted Shares Outstanding | 120.17M | 121.20M | 122.11M | 121.41M | 120.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |